Health ADC Therapeutics gibt die Annahme von Abstracts zur Präsentation auf der 65. ASH-Jahrestagung… James Pereira Nov 6, 2023 Präsentationen zur Hervorhebung des klinischen Nutzens von ZYNLONTA® (Loncastuximab-Tesirin-Lpyl) als Einzelwirkstoff… Read More...
Health ADC Therapeutics gibt Plan zur Einstellung der klinischen Phase-II-Studie LOTIS-9 zu ZYNLONTA®… James Pereira Jul 22, 2023 LAUSANNE, Schweiz, July 21, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) hat heute bekanntgegeben, dass… Read More...
Health ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA®… James Pereira Jul 21, 2023 LAUSANNE, Switzerland, July 20, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it… Read More...
Health ADC Therapeutics gibt freiwillige Unterbrechung der Aufnahme in die klinische Phase-II-Studie… James Pereira Jul 13, 2023 LAUSANNE, Schweiz, July 12, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) hat heute eine freiwillige… Read More...
Health Mablink Bioscience to Present Promising Preclinical Data for Lead ADC Candidate MBK-103 at the AACR… James Pereira Mar 15, 2023 <!-- Name:DistributionId Value:1000798103 --> <!--… Read More...
Health ADC Offers Promising Results in Relapsed or Refractory Hodgkin Lymphoma James Pereira Oct 3, 2022 Investigational camidanlumab tesirine led to a high… Read More...
Health Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Advanced Development Center (ADC)… James Pereira Jun 16, 2022 The ADC is Expected to Accelerate Clinical-Scale Manufacturing of Live Virus Vaccines, Including Vaccines for… Read More...
Health Novel ADC Promising in Tough-to-Treat Ovarian Cancer James Pereira Mar 20, 2022 PHOENIX -- Mirvetuximab soravtansine monotherapy demonstrated… Read More...
Health Trastuzumab ADC Active in HER2-Low, HER2-Undetected Breast Cancer James Pereira Dec 13, 2021 SAN ANTONIO -- A headline-making antibody-drug conjugate… Read More...
Health TROP2-Directed ADC Promising in Advanced Triple-Negative Breast Cancer James Pereira Dec 8, 2021 SAN ANTONIO -- The investigational agent datopotamab… Read More...